Following this premise, two large studies of patients with European-ancestry from the UK Biobank (UKB) cohort reported that individuals with APOE ε4∗ε4 genotype had an increase in the risk of developing severe COVID-19 and a four-fold increase in mortality after testing positive for COVID-19 [13,22]. The gene discussed is APOE; the disease is COVID-19.